Aptevo Therapeutics Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Aptevo Therapeutics Inc. (APVO) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$47.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-05.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2024-03-05
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2021-12-31 was $0.00.
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2021-09-30 was $1.00K.
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2021-06-30 was $0.00.
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2021-03-31 was -$5.00K.
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$47.00K.
- Aptevo Therapeutics Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$4.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$47.00K 10-K · filed 2024-03-05 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.00K derived: sum of 3 quarters · filed 2023-03-30 | -$4.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.00K derived: sum of 2 quarters · filed 2021-11-12 | -$4.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$5.00K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$5.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |